August 8, 2023analysis, analytics, BIPOC, black, business, Business Analysis, cannabis, compliance, Conference, consumer, CQC, CQCExpo, Dispensaries & Retail, dispensary, Dockery, drug, empowerment, entrepreneur, Federal, government, growing, industry, James, John, Johnson, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, new jersey, NJ, Operations, Parsippany, Quality, regulation, regulatory, retail, simply pure, social equity, state, Tahir, Tahir Johnson, test, Trenton, Wanda, war

Trenton Makes The World Takes: A Q&A with Tahir Johnson, CEO of Simply Pure Trenton

Tahir Johnson is the founder and CEO of Simply Pure Trenton, the first black-owned social equity dispensary to receive a license in […]

July 13, 20238, analysis, analytics, business, Business Analysis, candy, cannabis, cbd, claim, compliance, consumer, copycat, cure, Delta, delta 8, drug, Edibles & Processing, FDA, Federal, food, FTC, government, growing, Health, industry, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, product, regulation, regulations, regulatory, retail, safety, snack, state, test, thc, unsub, warning

FDA, FTC Issue Warnings to Delta 8 Copycat Cannabis Companies

Last week, the U.S. Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) sent out warning letters to six different […]

February 3, 2023administration, analysis, analytics, business, Business Analysis, cannabis, cbd, compliance, Concentrates & Extracts, consumer, cultivation, Cultivation & Growing, dea, Dispensaries & Retail, dispensary, drug, Edibles & Processing, extraction, farm bill, FDA, Federal, food, framework, government, growing, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, Operations, pathway, product, products, Quality, recreational, regulation, regulations, regulatory, safety, state, test, USDA

FDA Punts on CBD Rules

On December 20, 2018, Former President Trump signed the Farm Bill into law, which removed hemp-derived cannabidiol (CBD) from the Controlled Substances […]

December 10, 2022Affinity, analysis, analytics, bio, business, Business Analysis, cannabinoid, cannabis, Christina Diarcangelo, clinical, diabetic, drug, Federal, government, growing, head, industry, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, medical, medicine, nerve, pain, Partners, pharma, pharmaceutical, product, Product Development, Quality, regulation, regulatory, safety, state, studies, Study, test, Testing, therapeutics, to, trial, Zelira

First Pharma vs Cannabis Clinical Trial Moves Forward

Affinity Bio Partners on Working with Zelira Therapeutics to Complete Enrolment for Diabetic Nerve Pain Drug Trial It’s an exciting time in […]

July 7, 2022additive, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, consumer, data, derived, dietary, drug, Edibles & Processing, EFSA, EU, europe, extraction, FDA, Federal, food, Gendel Food Safety, government, gras, growing, hemp, industry, international, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, novel, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, review, safety, state, Steven Gendel, test, Testing, thc, US

CBD Safety in Edibles: What Regulators are Thinking

Despite the popularity of cannabidiol (CBD) infused edibles among consumers there are storm clouds on the horizon for this market. The potential […]

May 5, 20228, analysis, analytics, business, cannabidiol, cannabis, cbd, claim, compliance, consumer, cure, Delta, delta-8 THC, delta-8-tetrahydrocannabinol, delta-9 tetrahydrocannabinol, delta-9-THC, Dispensaries & Retail, drug, Edibles & Processing, FD&C act, FDA, Federal, government, growing, illegal, industry, lab, label, laboratories, laboratory, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, misbranded, prevent, product, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, treat, unapproved, update, violate, violation, warning

FDA Issues First Warning Letters for Delta-8 THC

In an unprecedented move, the U.S. Food & Drug Administration (FDA) has issued warning letters today to companies selling products containing delta-8 […]

April 20, 2022action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]

December 2, 2021analysis, analytics, brand, business, cannabis, claim, compliance, consumer, disclosure, Dispensaries & Retail, dispensary, drug, Edibles & Processing, FDA, FDCA, Federal, font, government, growing, Health, identify, identity, industry, ingredient, label, labeling, law, legal, legalization, legalize, legislation, license, location, marijuana, market, medical, medicine, name, nutrition facts, Operations, paper, plastic, polypropylene, product, Quality, recreational, regulation, regulations, regulatory, requirement, retail, safety, state, statement, test, Testing, thc, warning

The Do’s and Don’ts of Cannabis Labeling

As more states legalize the use of cannabis for both medicinal and adult use, the market is growing exponentially. For growers and […]

September 21, 2021Aaron Green, absorb, absorption, analysis, analytics, based, beverage, business, Business Analysis, cannabinoid, cannabis, cbd, co2, compound, Concentrates & Extracts, consumer, delivery, Dispensaries & Retail, dissolve, distill, distillation, distilled, drug, Edibles & Processing, emulsifier, emulsify, evaporative, extract, extraction, formulation, fragrance, growing, hops, industry, ion, ionize, ionized, Iridium consulting, legalization, legalize, license, lifetonic, marijuana, market, nanoemlusion, oil, patent, pending, portfolio, process, product, Product Development, Quality, recreational, regulation, regulations, retail, Russell Thomas, Technology, thc, vapor

Leaders in Cannabis Formulations: Part 4 – LifeTonic

Russell is the CEO of NES Technology Holdings, a technology development and marketing company that operates Vapor Distilled and LifeTonic Brands. NES […]

June 3, 2021Amazon, analysis, analytics, back, backing, business, cannabis, cbd, compliance, consumer, Dave Clark, drug, Federal, government, growing, industry, law, legal, legalization, legalize, legislation, license, marijuana, market, MORE Act, product, recreational, regulation, regulations, regulatory, retail, screen, screening, state, support, test, Testing, The Marijuana Opportunity Reinvestment and Expungement Act

Amazon Now Backs Federal Legalization

Amazon’s Senior Vice President of worldwide operations, Dave Clark, wrote a blog post yesterday that is making headlines in the cannabis community. […]